Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Non-daily contraceptives cause fewer side effects and are more satisfying to women, and certain oral contraceptives can treat acne and seborrhoea, with a combination of chlormadinone acetate and ethinyl estradiol being highly effective and safe.

Hair analysis can help diagnose adrenal disorders non-invasively.

Men prefer less invasive cosmetic procedures and need different treatment approaches than women.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

Oral minoxidil is as effective and safe as topical minoxidil for treating female pattern hair loss.

Skin and hair aging involves mitochondrial issues, telomere shortening, and hormonal changes, with iron affecting hair loss in pre-menopausal women.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

More men are getting cosmetic surgery, with Botox and hair removal being popular, but these procedures have risks.

New hair and scalp disease diagnosis methods are important for correct treatment.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

PRP injections effectively improve stress urinary incontinence in women.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Free testosterone is the most common hormone marker in PCOS, and age affects DHEAS levels.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Irisin and GIP levels are not linked to BMI in women, regardless of PCOS status.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Rasayana therapy can enhance female reproductive health at different life stages.